Skip to Content
 

VICC toll-free number 1-877-936-8422

Clinical Trials for OncoVEX GM-CSF

1 Open Trial

    Trial Type Protocol No. &
    Open Date
    Summary

    Other

    VICCMEL14103

    08/17/2015

    A Registry Study to Evaluate the Survival and Long-Term Safety of Subjects Who Previously Received Talimogene Laherparepvec in Amgen or BioVEX-Sponsored Clinical Trials


    Print this page for your doctor